Asthma Therapeutics Market - Global Outlook and Forecast 2021-2027

Publisher Name :
Date: 15-Oct-2021
No. of pages: 105

This report contains market size and forecasts of Asthma Therapeutics in Global, including the following market information:

Global Asthma Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Asthma Therapeutics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Asthma Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Asthma Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Asthma Therapeutics Market Segment Percentages, By Type, 2020 (%)

- Inhalation

- Parenteral

- Oral

China Asthma Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Asthma Therapeutics Market Segment Percentages, By Application, 2020 (%)

- Hospitals

- Clinics

Global Asthma Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Asthma Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Asthma Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Asthma Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

- AstraZeneca

- Boehringer Ingelheim

- F. Hoffmann-La Roche

- GSK

- Merck

- Horizon Pharma

- Mitsubishi Tanabe Pharma

- Sanofi

- Mundipharma

- Nycomed

- Kissei Pharmaceutical

- ALK-Abello

- Array BioPharma

- SAMA Pharmaceuticals

- Whanin Pharmaceutical

Asthma Therapeutics Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Asthma Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Asthma Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Asthma Therapeutics Overall Market Size
2.1 Global Asthma Therapeutics Market Size: 2021 VS 2027
2.2 Global Asthma Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Asthma Therapeutics Players in Global Market
3.2 Top Global Asthma Therapeutics Companies Ranked by Revenue
3.3 Global Asthma Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Asthma Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Asthma Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Asthma Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Asthma Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Asthma Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Asthma Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Inhalation
4.1.3 Parenteral
4.1.4 Oral
4.2 By Type - Global Asthma Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Asthma Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Asthma Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Asthma Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Asthma Therapeutics Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.2 By Application - Global Asthma Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Asthma Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Asthma Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Asthma Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Asthma Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Asthma Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Asthma Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Asthma Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Asthma Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Asthma Therapeutics Revenue, 2016-2027
6.3.2 US Asthma Therapeutics Market Size, 2016-2027
6.3.3 Canada Asthma Therapeutics Market Size, 2016-2027
6.3.4 Mexico Asthma Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Asthma Therapeutics Revenue, 2016-2027
6.4.2 Germany Asthma Therapeutics Market Size, 2016-2027
6.4.3 France Asthma Therapeutics Market Size, 2016-2027
6.4.4 U.K. Asthma Therapeutics Market Size, 2016-2027
6.4.5 Italy Asthma Therapeutics Market Size, 2016-2027
6.4.6 Russia Asthma Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Asthma Therapeutics Market Size, 2016-2027
6.4.8 Benelux Asthma Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Asthma Therapeutics Revenue, 2016-2027
6.5.2 China Asthma Therapeutics Market Size, 2016-2027
6.5.3 Japan Asthma Therapeutics Market Size, 2016-2027
6.5.4 South Korea Asthma Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Asthma Therapeutics Market Size, 2016-2027
6.5.6 India Asthma Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Asthma Therapeutics Revenue, 2016-2027
6.6.2 Brazil Asthma Therapeutics Market Size, 2016-2027
6.6.3 Argentina Asthma Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Asthma Therapeutics Revenue, 2016-2027
6.7.2 Turkey Asthma Therapeutics Market Size, 2016-2027
6.7.3 Israel Asthma Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Asthma Therapeutics Market Size, 2016-2027
6.7.5 UAE Asthma Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Asthma Therapeutics Major Product Offerings
7.1.4 AstraZeneca Asthma Therapeutics Revenue in Global (2016-2021)
7.1.5 AstraZeneca Key News
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Corporate Summary
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Asthma Therapeutics Major Product Offerings
7.2.4 Boehringer Ingelheim Asthma Therapeutics Revenue in Global (2016-2021)
7.2.5 Boehringer Ingelheim Key News
7.3 F. Hoffmann-La Roche
7.3.1 F. Hoffmann-La Roche Corporate Summary
7.3.2 F. Hoffmann-La Roche Business Overview
7.3.3 F. Hoffmann-La Roche Asthma Therapeutics Major Product Offerings
7.3.4 F. Hoffmann-La Roche Asthma Therapeutics Revenue in Global (2016-2021)
7.3.5 F. Hoffmann-La Roche Key News
7.4 GSK
7.4.1 GSK Corporate Summary
7.4.2 GSK Business Overview
7.4.3 GSK Asthma Therapeutics Major Product Offerings
7.4.4 GSK Asthma Therapeutics Revenue in Global (2016-2021)
7.4.5 GSK Key News
7.5 Merck
7.5.1 Merck Corporate Summary
7.5.2 Merck Business Overview
7.5.3 Merck Asthma Therapeutics Major Product Offerings
7.5.4 Merck Asthma Therapeutics Revenue in Global (2016-2021)
7.5.5 Merck Key News
7.6 Horizon Pharma
7.6.1 Horizon Pharma Corporate Summary
7.6.2 Horizon Pharma Business Overview
7.6.3 Horizon Pharma Asthma Therapeutics Major Product Offerings
7.6.4 Horizon Pharma Asthma Therapeutics Revenue in Global (2016-2021)
7.6.5 Horizon Pharma Key News
7.7 Mitsubishi Tanabe Pharma
7.7.1 Mitsubishi Tanabe Pharma Corporate Summary
7.7.2 Mitsubishi Tanabe Pharma Business Overview
7.7.3 Mitsubishi Tanabe Pharma Asthma Therapeutics Major Product Offerings
7.4.4 Mitsubishi Tanabe Pharma Asthma Therapeutics Revenue in Global (2016-2021)
7.7.5 Mitsubishi Tanabe Pharma Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Asthma Therapeutics Major Product Offerings
7.8.4 Sanofi Asthma Therapeutics Revenue in Global (2016-2021)
7.8.5 Sanofi Key News
7.9 Mundipharma
7.9.1 Mundipharma Corporate Summary
7.9.2 Mundipharma Business Overview
7.9.3 Mundipharma Asthma Therapeutics Major Product Offerings
7.9.4 Mundipharma Asthma Therapeutics Revenue in Global (2016-2021)
7.9.5 Mundipharma Key News
7.10 Nycomed
7.10.1 Nycomed Corporate Summary
7.10.2 Nycomed Business Overview
7.10.3 Nycomed Asthma Therapeutics Major Product Offerings
7.10.4 Nycomed Asthma Therapeutics Revenue in Global (2016-2021)
7.10.5 Nycomed Key News
7.11 Kissei Pharmaceutical
7.11.1 Kissei Pharmaceutical Corporate Summary
7.11.2 Kissei Pharmaceutical Business Overview
7.11.3 Kissei Pharmaceutical Asthma Therapeutics Major Product Offerings
7.11.4 Kissei Pharmaceutical Asthma Therapeutics Revenue in Global (2016-2021)
7.11.5 Kissei Pharmaceutical Key News
7.12 ALK-Abello
7.12.1 ALK-Abello Corporate Summary
7.12.2 ALK-Abello Business Overview
7.12.3 ALK-Abello Asthma Therapeutics Major Product Offerings
7.12.4 ALK-Abello Asthma Therapeutics Revenue in Global (2016-2021)
7.12.5 ALK-Abello Key News
7.13 Array BioPharma
7.13.1 Array BioPharma Corporate Summary
7.13.2 Array BioPharma Business Overview
7.13.3 Array BioPharma Asthma Therapeutics Major Product Offerings
7.13.4 Array BioPharma Asthma Therapeutics Revenue in Global (2016-2021)
7.13.5 Array BioPharma Key News
7.14 SAMA Pharmaceuticals
7.14.1 SAMA Pharmaceuticals Corporate Summary
7.14.2 SAMA Pharmaceuticals Business Overview
7.14.3 SAMA Pharmaceuticals Asthma Therapeutics Major Product Offerings
7.14.4 SAMA Pharmaceuticals Asthma Therapeutics Revenue in Global (2016-2021)
7.14.5 SAMA Pharmaceuticals Key News
7.15 Whanin Pharmaceutical
7.15.1 Whanin Pharmaceutical Corporate Summary
7.15.2 Whanin Pharmaceutical Business Overview
7.15.3 Whanin Pharmaceutical Asthma Therapeutics Major Product Offerings
7.15.4 Whanin Pharmaceutical Asthma Therapeutics Revenue in Global (2016-2021)
7.15.5 Whanin Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Asthma Therapeutics Market Opportunities & Trends in Global Market
Table 2. Asthma Therapeutics Market Drivers in Global Market
Table 3. Asthma Therapeutics Market Restraints in Global Market
Table 4. Key Players of Asthma Therapeutics in Global Market
Table 5. Top Asthma Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Asthma Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Asthma Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Asthma Therapeutics Product Type
Table 9. List of Global Tier 1 Asthma Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Asthma Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Asthma Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Asthma Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Asthma Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Asthma Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Asthma Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Asthma Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Asthma Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Asthma Therapeutics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Asthma Therapeutics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Asthma Therapeutics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Asthma Therapeutics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Asthma Therapeutics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Asthma Therapeutics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Asthma Therapeutics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Asthma Therapeutics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Asthma Therapeutics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Asthma Therapeutics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Asthma Therapeutics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Asthma Therapeutics Revenue, (US$, Mn), 2022-2027
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Asthma Therapeutics Product Offerings
Table 32. AstraZeneca Asthma Therapeutics Revenue (US$, Mn), (2016-2021)
Table 33. Boehringer Ingelheim Corporate Summary
Table 34. Boehringer Ingelheim Asthma Therapeutics Product Offerings
Table 35. Boehringer Ingelheim Asthma Therapeutics Revenue (US$, Mn), (2016-2021)
Table 36. F. Hoffmann-La Roche Corporate Summary
Table 37. F. Hoffmann-La Roche Asthma Therapeutics Product Offerings
Table 38. F. Hoffmann-La Roche Asthma Therapeutics Revenue (US$, Mn), (2016-2021)
Table 39. GSK Corporate Summary
Table 40. GSK Asthma Therapeutics Product Offerings
Table 41. GSK Asthma Therapeutics Revenue (US$, Mn), (2016-2021)
Table 42. Merck Corporate Summary
Table 43. Merck Asthma Therapeutics Product Offerings
Table 44. Merck Asthma Therapeutics Revenue (US$, Mn), (2016-2021)
Table 45. Horizon Pharma Corporate Summary
Table 46. Horizon Pharma Asthma Therapeutics Product Offerings
Table 47. Horizon Pharma Asthma Therapeutics Revenue (US$, Mn), (2016-2021)
Table 48. Mitsubishi Tanabe Pharma Corporate Summary
Table 49. Mitsubishi Tanabe Pharma Asthma Therapeutics Product Offerings
Table 50. Mitsubishi Tanabe Pharma Asthma Therapeutics Revenue (US$, Mn), (2016-2021)
Table 51. Sanofi Corporate Summary
Table 52. Sanofi Asthma Therapeutics Product Offerings
Table 53. Sanofi Asthma Therapeutics Revenue (US$, Mn), (2016-2021)
Table 54. Mundipharma Corporate Summary
Table 55. Mundipharma Asthma Therapeutics Product Offerings
Table 56. Mundipharma Asthma Therapeutics Revenue (US$, Mn), (2016-2021)
Table 57. Nycomed Corporate Summary
Table 58. Nycomed Asthma Therapeutics Product Offerings
Table 59. Nycomed Asthma Therapeutics Revenue (US$, Mn), (2016-2021)
Table 60. Kissei Pharmaceutical Corporate Summary
Table 61. Kissei Pharmaceutical Asthma Therapeutics Product Offerings
Table 62. Kissei Pharmaceutical Asthma Therapeutics Revenue (US$, Mn), (2016-2021)
Table 63. ALK-Abello Corporate Summary
Table 64. ALK-Abello Asthma Therapeutics Product Offerings
Table 65. ALK-Abello Asthma Therapeutics Revenue (US$, Mn), (2016-2021)
Table 66. Array BioPharma Corporate Summary
Table 67. Array BioPharma Asthma Therapeutics Product Offerings
Table 68. Array BioPharma Asthma Therapeutics Revenue (US$, Mn), (2016-2021)
Table 69. SAMA Pharmaceuticals Corporate Summary
Table 70. SAMA Pharmaceuticals Asthma Therapeutics Product Offerings
Table 71. SAMA Pharmaceuticals Asthma Therapeutics Revenue (US$, Mn), (2016-2021)
Table 72. Whanin Pharmaceutical Corporate Summary
Table 73. Whanin Pharmaceutical Asthma Therapeutics Product Offerings
Table 74. Whanin Pharmaceutical Asthma Therapeutics Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Asthma Therapeutics Segment by Type
Figure 2. Asthma Therapeutics Segment by Application
Figure 3. Global Asthma Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Asthma Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Asthma Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Asthma Therapeutics Revenue in 2020
Figure 8. By Type - Global Asthma Therapeutics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Asthma Therapeutics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Asthma Therapeutics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Asthma Therapeutics Revenue Market Share, 2016-2027
Figure 12. US Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Asthma Therapeutics Revenue Market Share, 2016-2027
Figure 16. Germany Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 17. France Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Asthma Therapeutics Revenue Market Share, 2016-2027
Figure 24. China Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 28. India Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Asthma Therapeutics Revenue Market Share, 2016-2027
Figure 30. Brazil Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Asthma Therapeutics Revenue Market Share, 2016-2027
Figure 33. Turkey Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Asthma Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 37. AstraZeneca Asthma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Boehringer Ingelheim Asthma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. F. Hoffmann-La Roche Asthma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. GSK Asthma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Merck Asthma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Horizon Pharma Asthma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Mitsubishi Tanabe Pharma Asthma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Sanofi Asthma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Mundipharma Asthma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Nycomed Asthma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Kissei Pharmaceutical Asthma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. ALK-Abello Asthma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Array BioPharma Asthma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. SAMA Pharmaceuticals Asthma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Montelukast Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Montelukast Sodium market size was valued at US$ 336.3 million in 2023. With growing demand in downstream market, the Montelukast Sodium is forecast to a readjusted size of US$ 815.4 million by 2030 with a CAGR of 13.5% during review period. The research report highlights the growth potential of the global Montelukast Sodium market. Montelukast Sodium are expected to show stable growth in the future market. However, product d......
  • Global Montelukast Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 132
    According to our (Global Info Research) latest study, the global Montelukast Sodium market size was valued at USD 353.8 million in 2023 and is forecast to a readjusted size of USD 803.8 million by 2030 with a CAGR of 12.4% during review period. Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chr......
  • Asthma Therapeutics - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 114
    The global Asthma Therapeutics market size is expected to reach US$ 27800 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Asthma Therapeutics in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Asthma Therapeutics market. Inhalation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......
  • Global Asthma Therapeutics Market Research Report 2023, Forecast to 2028
    Published: 15-Dec-2023        Price: US 2680 Onwards        Pages: 163
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Budesonide Aerosol Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 146
    Report Overview: The Global Budesonide Aerosol Market Size was estimated at USD 7996.70 million in 2022 and is projected to reach USD 41912.84 million by 2029, exhibiting a CAGR of 26.70% during the forecast period. This report provides a deep insight into the global Budesonide Aerosol market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key marke......
  • Global Asthma Therapeutics Professional Survey Report 2023, Forecast to 2028
    Published: 15-Dec-2023        Price: US 3280 Onwards        Pages: 139
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Montelukast Sodium Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 144
    Report Overview: Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis. The Global Montelukast Sodium Market Size was estimated at USD 816.70 million in 2022 and is projected to reach USD 1921.37 million by 20......
  • Global Doxofylline (API) Market Research Report 2023
    Published: 28-Nov-2023        Price: US 2900 Onwards        Pages: 88
    Doxofylline (also known as doxophylline) is a phosphodiesterase inhibiting bronchodilator used in The treatment of chronic respiratory diseases such as asthma and COPD. Like theophylline, it is a xanthine derivative. According to QYResearch's new survey, global Doxofylline (API) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with The CAGR of % during The period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Uk......
  • Global Montelukast Sodium Market Research Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 164
    Montelukast sodium is an organic sodium salt. Montelukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma and has been linked to rare cases of clinically apparent liver injury. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs